Belcher Tells Fed. Circ. Inequitable Conduct Order Implausible
A district court erroneously found that Belcher Pharmaceuticals LLC obtained an epinephrine injection patent through inequitable conduct, disregarding a more plausible explanation for why it didn't disclose prior art during prosecution,...To view the full article, register now.
Already a subscriber? Click here to view full article